Immunosuppressant therapy of thyroid eye disease

Klinische Wochenschrift

Volumn 66, Issue 21, 1988, Pages 1049-1059

  Kahaly, G ^a   Beyer, J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Glucocorticoids; Nonsteroid immunosuppressants; Plasmapheresis; Radiotherapy

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CIAMEXON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; FLUOCORTOLONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADULT; EYE DISEASE; GRAVES DISEASE; HUMAN; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

GRAVES' DISEASE; HUMAN; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS;

EID: 0023798736     PISSN: 00232173     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/BF01711917     Document Type: Review

References (93)

1. Exophthalmos in autoimmune thyroid disease
2. Management of thyrotoxicosis in patients with ophthalmopathy: antithyroid regimen determined primarily by ocular manifestations
3. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone
4. Radioactive iodine therapy for progressive malignant exophthalmos
5. Pathogenetische Vorstellungen und Klinik der Endokrinen Ophthalmopathie
6. Die totale Thyreoidektomie im Behandlungsplan der endokrinen Orbitopathie
7. Ciamexone, a highly selective immunomodulator — a tool for autoimmune diseases?
8. Cyclophosphamide in the management of advanced Graves' ophthalmopathy
9. Thyroglobulin independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy
10. The mechanism of action of ciclosporin: a continuing puzzle
11. Cyclosporin in infiltrative eye disorder
12. Cortisone in exophthalmos
13. Adrenal steroid therapy of severe infiltrative ophthalmo pathy of Graves' disease
14. Ophthalmopathy associated with primary hypothyroidism
15. Immunosuppressive therapy for eye changes of Graves' disease
16. Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease
17. Thyroid eye disease: natural history and response to hyperthyroidism treatment
18. Medical therapy of thyroid ophthalmopathy
19. Radiation therapy for thyroid eye disease
20. Radiation therapy for exophthalmos
21. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis
22. Corticosteroids in the treatment of optic nerve involvment
23. Supervoltage orbital radiotherapy for Graves' ophthalmopathy
24. Appearance of Graves' disease on orbital computed tomography
25. Graves' disease and HLA: clinical and epidemiologic association
26. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography
27. Prevalence of increased intraocular pressure in Graves' ophthalmopathy — evidence of frequent subclinical ophthalmopathy
28. Methylprednisolon in the treatment of exophthalmos
29. Depot-methylprednisolone for subconjunctival and retrobulbar injections
30. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy
31. Extrathyroid manifestations of Graves' disease
32. Effect on exophthalmos of various methods of treatment of Graves' disease
33. Ocular changes in Graves' disease
34. Strahlentherapie der endokrinen Ophthalmopathie mit 18 MeV Bremsstrahlung
35. Diagnostik und Therapie der endokrinen Ophthalmopathie
36. Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment
37. Der Langzeitverlauf der Endokrinen Orbitopathie unter thyreostatischer Therapie: Eine retrospektive Studie
38. Medical approach to ophthalmopathy of Graves' disease
39. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment
40. Derzeitiger Stand der medikamentösen Therapie der Endokrinen Ophthalmopathie. Eine Übersicht
41. Remission — maintaining effect of cyclosporin in endocrine ophthalmopathy
42. Ciclosporin and prednisone vs prednisone in treatment of Graves' ophthalmopathy — a controlled, randomized and prospective study
43. Untersuchungen zum Einfluß von Cyclosporin A auf die Endokrine Ophthalmopathie
44. Thyreozyten stimulierende und Augenmuskelantikörper bei Morbus Basedow und Endokriner Orbitopathie
45. A pilot study of ciclosporin in endocrine ophthalmopathy
46. An evaluation of plasma exchange for Graves' ophthalmopathy
47. The pathogenesis of Graves' ophthalmopathy
48. Ergebnisse in der Therapie der Endokrinen Ophthalmopathie in den Jahren 1978–1981
49. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves ophthalmopathy
50. Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease
51. Cell-mediated lysis of lipid vesicles containing eye muscle proteins: implication regarding pathogenesis of Graves' ophthalmopathy
52. Retrobulbärbestrahlung bei der endokrinen Ophthalmopathie
53. Demonstration of delayed hypersensitivity in retrobulbar and thyroid tissues in human exophthalmos
54. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study
55. Medical therapy
56. Primary structure of bovine thyroglobulin deduced from the sequence of its 8431-complementary DNA
57. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle
58. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF)
59. Large doses of radio iodine in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator
60. Diagnostik und Therapie der Endokrinen Ophthalmopathie an der DKD
61. Radiotherapy of Graves' ophthalmopathy
62. Therapie der endokrinen Ophthalmopathie
63. Discussion of paper by Ivy HK (1972) Medical approach to ophthalmopathy of Graves' disease
64. Orbital pathology in Graves' disease
65. Therapieergebnisse (einschließlich Immunsuppressiva) bei 161 Patienten mit Endokriner Ophthalmopathie
66. Verlauf der endokrinen Ophthalmopathie und Effektivität der etablierten therapeutischen Maßnahmen
67. Behandlung der frischen infiltrativen Orbitopathie
68. E-rosette formation in Graves' ophthalmopathy
69. The lymphocytes sera and long-acting thyroid stimulator patients with Graves' disease on retrobulbar fibroblasts
70. The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study
71. Changes in thyroid functions in patients with euthyroid Graves' disease
72. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy
73. Strahlentherapie der endokrinen Ophthalmopathie. Auswertung von 56 Fällen
74. Möglichkeiten der Therapie der Endokrinen Ophthalmopathie
75. Treatment of severe Graves' ophthalmopathy with cyclosporin A
76. Exophthalmos durch Hypertrophie des Zellgewebes in der Augenhöhle
77. Ciclosporin in autoimmune disease. Side effects with emphasis on renal dysfunction and recommendations for use
78. Autoimmunity and Graves' ophthalmopathy
79. Immunological factors in thyroid disease
80. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide
81. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy
82. Cyclosporin improves Graves' ophthalmopathy
83. Prednisone in emergency treatment of malignant exophthalmos
84. Modification of the eye changes of Graves' disease
85. Graves' disease and total thyroidectomy: progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation
86. Total thyroid ablation: a prerequisite to orbital decompression for Graves' disease ophthalmopathy
87. Prevention of malignant exophthalmos after treatment of thyrotoxicosis
88. Treatment of Graves' ophthalmopathy with cyclosporin A
89. Die Endokrine Orbitopathie bei diffuser Hyperthyreose unter thyreostatischer Therapie